Royalty Pharma PLC
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$26.37avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Royalty Pharma PLC in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was DNB Asset Management AS ($1.9M).
- Company
- Royalty Pharma PLC
- CUSIP
- 00BMVP7Y0
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 14,042 shares bought, net +14,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| DNB Asset Management AS | 0.01% | Add +24.5% | 71,317 | $1.9M |
"% of holder's portfolio" is Royalty Pharma PLC's weight in each manager's 13F, not the share of Royalty Pharma PLC the manager owns.